Singapore markets closed
Straits Times Index
3,190.71 -34.64 (-1.07%) S&P 500
3,899.01 -24.67 (-0.63%) Dow
31,139.33 -350.74 (-1.11%) Nasdaq
11,448.65 +30.49 (+0.27%) BTC-USD
29,923.52 +777.33 (+2.67%) CMC Crypto 200
665.16 +12.93 (+1.98%)
GlaxoSmithKline plc (GSK)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 11:19AM EDT. Market open.
| Previous close | 43.28 |
| Open | 43.08 |
| Bid | 43.51 x 1200 |
| Ask | 43.52 x 1800 |
| Day's range | 43.06 - 43.53 |
| 52-week range | 37.80 - 46.97 |
| Volume | |
| Avg. volume | 5,142,686 |
| Market cap | 110.297B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 17.54 |
| EPS (TTM) | 2.47 |
| Earnings date | 01 Feb 2017 - 06 Feb 2017 |
| Forward dividend & yield | 1.99 (4.48%) |
| Ex-dividend date | 19 May 2022 |
| 1y target est | 49.81 |
- Zacks
4 Large Drug Stocks to Watch as the Industry Recovers
Drug/biotech companies are likely to see significant advances in innovation in 2022. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and Glaxo (GSK) are worth retaining in your portfolio.
- Zacks
AstraZeneca (AZN) Inks Deal to Develop COVID-19 Antibodies
AstraZeneca (AZN) partners with a U.K.-based biotech company to develop monoclonal antibodies targeting the COVID-causing virus.
- Zacks
Gilead (GILD) HIV Studies Removed From FDA's Clinical Hold
Gilead (GILD) studies evaluating injectable lenacapavir for HIV treatment and HIV pre-exposure prophylaxis (PrEP) removed from hold.
© 2022 Yahoo. All rights reserved.
